1. Zevalin (ibritumomab tiuxetan) prescribing information,2002
2. Radioimmunoscintigraphy and radioimmunotherapy in cancer;Potamianos;Anticancer Res,2000
3. Radioimmunotherapy of lymphomas and leukemias;Kuzel,1996
4. Administration guidelines for radioimmunotherapy of non-Hodgkin’s lymphoma with 90Y-labeled anti-CD20 monoclonal antibody;Wagner;J Nucl Med,2002
5. Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin’s lymphoma;Wiseman;Eur J Nucl Med,2000